Want more details on what’s going on at PURE Bioscience, regarding the company’s growth strategy? Find out directly from the CEO!
PURE Bioscience, makers of IV-7 Ultimate Germ DefensePURE President and CEO Michael L. Krall will present to investors as part of the Lippert/Heilshorn & Associates Life Sciences & Medical Technologies On-line Forum on July 20, 2010 at 10:30 a.m. Eastern time. The presentation will provide a corporate overview and discuss the Company’s growth strategy.
Interested parties can access a live audio webcast with slide presentation at http://www.purebio.com/, or from the PrecisionIR site at http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=160292.
An archived presentation will be available for 30 days.
PURE Bioscience owns the patent for the IV-7 molecule (silver dihydrogen citrate, also known as SDC). If you want an insiders view of what’s going on at PURE, watch this online forum. It’s FREE.
Related posts:
IV-7 Ultimate Germ Defense and PURE BioscienceWow! IV-7 ELIMINATES MRSA for 14 Months in Tulsa County Jail!Pure Bioscience Gets 7th US PatentHere We (PURE Bioscience) Grow Again!Pure Bioscience (creators of IV-7) is a seriously Hot Stock
No comments:
Post a Comment